LEO Pharma A/S et al v. Teva Pharmaceuticals USA, Inc.
| LEO Pharma A/S, Foamix Pharmaceuticals Ltd. and LEO Pharma Inc. |
| Teva Pharmaceuticals USA, Inc. |
| 1:2019cv01282 |
| July 9, 2019 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 5, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 [SEALED] STIPULATION to Stay by Foamix Pharmaceuticals Ltd., LEO Pharma A/S, LEO Pharma Inc.. (Blumenfeld, Jack) |
SO ORDERED, re #9 STIPULATION TO EXTEND TIME for: 1) Defendant Teva Pharmaceuticals USA, Inc. to move, plead, or otherwise respond to the Complaint (D.I. 1) and 2) Plaintiffs' to answer any asserted counterclaims to December 20, 2019 and January 10, 2020, respecti filed by LEO Pharma Inc., Foamix Pharmaceuticals Ltd., LEO Pharma A/S, Set/Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 12/20/2019. Signed by Judge Colm F. Connolly on 8/23/2019. (nmf)
|
| Filing 9 STIPULATION TO EXTEND TIME for: 1) Defendant Teva Pharmaceuticals USA, Inc. to move, plead, or otherwise respond to the Complaint (D.I. 1) and 2) Plaintiffs' to answer any asserted counterclaims to December 20, 2019 and January 10, 2020, respectively - filed by Foamix Pharmaceuticals Ltd., LEO Pharma A/S, LEO Pharma Inc.. (Raucci, Anthony) |
| Filing 8 STIPULATION TO EXTEND TIME to Answer Complaint to August 30, 2019 - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
|
SO ORDERED, re #8 STIPULATION TO EXTEND TIME to Answer Complaint to August 30, 2019 filed by Teva Pharmaceuticals USA, Inc., Set/Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 8/30/2019. Signed by Judge Colm F. Connolly on 7/31/2019. (nmf)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 7 Return of Service Executed by LEO Pharma Inc., LEO Pharma A/S, Foamix Pharmaceuticals Ltd.. Teva Pharmaceuticals USA, Inc. served on 7/11/2019, answer due 8/1/2019. (Raucci, Anthony) |
| Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 7/10/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (myr) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Foamix Pharmaceuticals Ltd.. (myr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent The LEO Foundation for LEO Pharma A/S; Corporate Parent LEO Pharma A/S for LEO Pharma Inc. filed by LEO Pharma A/S, LEO Pharma Inc. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,322,085 B2. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 10/24/2023. (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2681871.) - filed by LEO Pharma Inc., LEO Pharma A/S, Foamix Pharmaceuticals Ltd.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
